Variant report
Variant | nsv961926 |
---|---|
Chromosome Location | chr2:208920553-208924250 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:5)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:5 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | JUND | chr2:208921872-208922310 | HepG2 | liver: | n/a | n/a |
2 | POLR2A | chr2:208924234-208924371 | GM12878 | blood: | n/a | n/a |
3 | POLR2A | chr2:208922080-208922340 | Hela-S3 | cervix: | n/a | n/a |
4 | POLR2A | chr2:208922093-208922324 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | ZBTB33 | chr2:208922040-208922384 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
RNA5SP116 | TF binding region |
ENSG00000224839 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs550059160 | chr2:208920557-208920558 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs77376172 | chr2:208920632-208920633 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535413473 | chr2:208920658-208920659 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs367816120 | chr2:208920673-208920674 | Weak transcription Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371719039 | chr2:208920854-208920855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371468586 | chr2:208920896-208920897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187619441 | chr2:208920897-208920898 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376470498 | chr2:208921038-208921039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs528298926 | chr2:208921046-208921047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565802697 | chr2:208921087-208921088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192602100 | chr2:208921127-208921128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558378731 | chr2:208921231-208921232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs17641035 | chr2:208921257-208921258 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs537360355 | chr2:208921271-208921272 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557187263 | chr2:208921360-208921361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573722556 | chr2:208921361-208921362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562083581 | chr2:208921423-208921424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542580762 | chr2:208921454-208921455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544432238 | chr2:208921534-208921535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs573330403 | chr2:208921538-208921539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs545161617 | chr2:208921539-208921540 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372012546 | chr2:208921561-208921562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs532936529 | chr2:208921569-208921570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538914123 | chr2:208921587-208921588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs78268370 | chr2:208921588-208921589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs58135597 | chr2:208921602-208921603 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs376592715 | chr2:208921668-208921669 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs60654512 | chr2:208921684-208921685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs550119997 | chr2:208921708-208921709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199948047 | chr2:208921774-208921775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184792764 | chr2:208921783-208921784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs150142544 | chr2:208921788-208921789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs549027683 | chr2:208921801-208921802 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs565536552 | chr2:208921805-208921806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs190172530 | chr2:208921823-208921824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs181870430 | chr2:208921865-208921866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571817415 | chr2:208921883-208921884 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs537222710 | chr2:208921903-208921904 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs73983677 | chr2:208921905-208921906 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs60755294 | chr2:208921912-208921913 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs201505937 | chr2:208921913-208921914 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs74577733 | chr2:208921915-208921916 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs553369994 | chr2:208921916-208921917 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs73983678 | chr2:208921932-208921933 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs545485200 | chr2:208921946-208921947 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs565204870 | chr2:208921947-208921948 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs577927345 | chr2:208921970-208921971 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs543676251 | chr2:208921992-208921993 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs138558627 | chr2:208922000-208922001 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs184862377 | chr2:208922071-208922072 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Cervical cancer | 21062161 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 16573809 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Autism | 20808228 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:208912800-208929400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr2:208919800-208920800 | Bivalent Enhancer | H9 Derived Neuron Cultured Cells | ES cell derived |